Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].
- DOI
- 10.1016/j.eclinm.2026.104079
- Published
- 2026 Aug
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2026.104079,
title = {Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].},
author = {De Santis MC and Campbell C and Samy F and De Rose F and Meduri B and Lambertini M and Sotiriou C and Carnevale MG and Ferro A and Saura C and Choudhury A and Giandini C and Verderio P and Chumsri S and Appierto V and Piccart M and Pruneri G and Colciago RR and de Azambuja E and Di Cosimo S},
year = {2026},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2026.104079},
url = {https://doi.org/10.1016/j.eclinm.2026.104079}
}RIS
TY - JOUR TI - Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)]. AU - De Santis MC AU - Campbell C AU - Samy F AU - De Rose F AU - Meduri B AU - Lambertini M AU - Sotiriou C AU - Carnevale MG AU - Ferro A AU - Saura C AU - Choudhury A AU - Giandini C AU - Verderio P AU - Chumsri S AU - Appierto V AU - Piccart M AU - Pruneri G AU - Colciago RR AU - de Azambuja E AU - Di Cosimo S PY - 2026 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2026.104079 UR - https://doi.org/10.1016/j.eclinm.2026.104079 ER -
APA
MC, D. S., C, C., F, S., F, D. R., B, M., M, L., C, S., MG, C., A, F., C, S., A, C., C, G., P, V., S, C., V, A., M, P., G, P., RR, C., E, D. A., & S, D. C. (2026). Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)].. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104079
Source records
- pubmed · retrieved 2026-09-25T16:20:09.025Z